PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Apr 30, 2020, after the close
10-Q filed Apr 30, 2020, 30 days after period end · 0001070081-20-000096
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $68.26M | $53.58M | $56.06M | $26.44M |
| Net Income | -$112.69M | -$72.11M | -$19.26M | -$29.06M |
| EPS Diluted |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$1.81 |
| -$1.29 |
| -$0.46 |
| -$0.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.